April 26-29, 2027
Hynes Convention CenterBoston, MA Maryke FehlauCTO at BioNukleoSpeaker
Profile
Dr. Maryke Fehlau is CTO and co-founder of the German Biotech company BioNukleo. She received her Ph.D. in biotechnology from the Technical University Berlin for the enzymatic synthesis of nucleoside triphosphates and has now over 10 years experience in biocatalysis and bioprocess development of nucleic acid building blocks. She is passionate about partnering with companies to help them implement biocatalytic solutions and advancing manufacturing technologies to make tomorrow’s drug production more sustainable.
Agenda Sessions
Biomanufacturing of Modified Nucleoside-5′-triphosphates (5´-NTP) as Building-blocks for the Enzymatic Assembly of Oligonucleotides
, 9:00amView Session